HEADER TRANSFERASE 03-JAN-18 6FEW TITLE DDR1, 2-[8-(1H-INDAZOLE-5-CARBONYL)-4-OXO-1-PHENYL-1,3,8- TITLE 2 TRIAZASPIRO[4.5]DECAN-3-YL]-N-METHYLACETAMIDE, 1.440A, P1211, TITLE 3 RFREE=24.1% COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EPITHELIAL DISCOIDIN DOMAIN RECEPTOR 1,CD167 ANTIGEN-LIKE COMPND 5 FAMILY MEMBER A,CELL ADHESION KINASE,DISCOIDIN RECEPTOR TYROSINE COMPND 6 KINASE,HGK2,MAMMARY CARCINOMA KINASE 10,MCK-10,PROTEIN-TYROSINE COMPND 7 KINASE 3A,PROTEIN-TYROSINE KINASE RTK-6,TRK E,TYROSINE KINASE DDR, COMPND 8 TYROSINE-PROTEIN KINASE CAK; COMPND 9 EC: 2.7.10.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS RTK, RECEPTOR TYROSINE KINASE, COLLAGEN, DISCOIDIN DOMAIN;, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.STIHLE,H.RICHTER,J.BENZ,B.KUHN,M.G.RUDOLPH REVDAT 2 27-MAR-19 6FEW 1 JRNL REVDAT 1 28-NOV-18 6FEW 0 JRNL AUTH H.RICHTER,A.L.SATZ,M.BEDOUCHA,B.BUETTELMANN,A.C.PETERSEN, JRNL AUTH 2 A.HARMEIER,R.HERMOSILLA,R.HOCHSTRASSER,D.BURGER,B.GSELL, JRNL AUTH 3 R.GASSER,S.HUBER,M.N.HUG,B.KOCER,B.KUHN,M.RITTER, JRNL AUTH 4 M.G.RUDOLPH,F.WEIBEL,J.MOLINA-DAVID,J.J.KIM,J.V.SANTOS, JRNL AUTH 5 M.STIHLE,G.J.GEORGES,R.D.BONFIL,R.FRIDMAN,S.UHLES,S.MOLL, JRNL AUTH 6 C.FAUL,A.FORNONI,M.PRUNOTTO JRNL TITL DNA-ENCODED LIBRARY-DERIVED DDR1 INHIBITOR PREVENTS FIBROSIS JRNL TITL 2 AND RENAL FUNCTION LOSS IN A GENETIC MOUSE MODEL OF ALPORT JRNL TITL 3 SYNDROME. JRNL REF ACS CHEM.BIOL. V. 14 37 2019 JRNL REFN ESSN 1554-8937 JRNL PMID 30452219 JRNL DOI 10.1021/ACSCHEMBIO.8B00866 REMARK 2 REMARK 2 RESOLUTION. 1.44 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_1803 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.44 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 53095 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 2705 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.4406 - 3.8417 1.00 2807 150 0.1515 0.1544 REMARK 3 2 3.8417 - 3.0495 1.00 2722 168 0.1755 0.2264 REMARK 3 3 3.0495 - 2.6641 1.00 2724 160 0.1942 0.1961 REMARK 3 4 2.6641 - 2.4205 1.00 2755 137 0.1966 0.2473 REMARK 3 5 2.4205 - 2.2470 0.93 2505 133 0.2291 0.2526 REMARK 3 6 2.2470 - 2.1146 0.92 2489 140 0.2346 0.2691 REMARK 3 7 2.1146 - 2.0087 1.00 2726 153 0.2058 0.2396 REMARK 3 8 2.0087 - 1.9212 0.93 2517 149 0.2685 0.3182 REMARK 3 9 1.9212 - 1.8473 0.88 2400 123 0.4017 0.4535 REMARK 3 10 1.8473 - 1.7835 0.99 2738 151 0.2295 0.2342 REMARK 3 11 1.7835 - 1.7278 1.00 2693 140 0.2264 0.2486 REMARK 3 12 1.7278 - 1.6784 1.00 2724 138 0.2211 0.2706 REMARK 3 13 1.6784 - 1.6342 1.00 2701 136 0.2452 0.2806 REMARK 3 14 1.6342 - 1.5943 1.00 2717 158 0.2807 0.3303 REMARK 3 15 1.5943 - 1.5581 1.00 2701 142 0.3137 0.3240 REMARK 3 16 1.5581 - 1.5249 0.99 2733 123 0.3263 0.3303 REMARK 3 17 1.5249 - 1.4944 0.99 2709 148 0.3681 0.3929 REMARK 3 18 1.4944 - 1.4662 0.87 2357 126 0.5040 0.5116 REMARK 3 19 1.4662 - 1.4400 0.99 2672 130 0.3860 0.3823 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.520 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2447 REMARK 3 ANGLE : 1.089 3314 REMARK 3 CHIRALITY : 0.075 355 REMARK 3 PLANARITY : 0.005 451 REMARK 3 DIHEDRAL : 12.804 947 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 603 THROUGH 678 ) REMARK 3 ORIGIN FOR THE GROUP (A): -8.4651 -8.9766 24.6584 REMARK 3 T TENSOR REMARK 3 T11: 0.3438 T22: 0.2723 REMARK 3 T33: 0.1999 T12: -0.0288 REMARK 3 T13: 0.0566 T23: -0.0256 REMARK 3 L TENSOR REMARK 3 L11: 0.3563 L22: 2.0927 REMARK 3 L33: 2.2334 L12: -0.2873 REMARK 3 L13: -0.6205 L23: 1.2611 REMARK 3 S TENSOR REMARK 3 S11: 0.1693 S12: -0.2139 S13: 0.0852 REMARK 3 S21: 0.3342 S22: -0.1654 S23: 0.1293 REMARK 3 S31: -0.0555 S32: -0.2428 S33: 0.0371 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 679 THROUGH 911 ) REMARK 3 ORIGIN FOR THE GROUP (A): 5.9161 0.8318 5.6641 REMARK 3 T TENSOR REMARK 3 T11: 0.0938 T22: 0.1180 REMARK 3 T33: 0.1258 T12: 0.0001 REMARK 3 T13: -0.0063 T23: -0.0138 REMARK 3 L TENSOR REMARK 3 L11: 0.9373 L22: 1.8150 REMARK 3 L33: 1.5654 L12: 0.2379 REMARK 3 L13: -0.1302 L23: -0.4039 REMARK 3 S TENSOR REMARK 3 S11: 0.0016 S12: -0.0577 S13: 0.0348 REMARK 3 S21: 0.0485 S22: -0.0326 S23: -0.0396 REMARK 3 S31: 0.0257 S32: 0.0473 S33: 0.0293 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6FEW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-JAN-18. REMARK 100 THE DEPOSITION ID IS D_1200008188. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53860 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.440 REMARK 200 RESOLUTION RANGE LOW (A) : 43.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 3.260 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : 0.05800 REMARK 200 FOR THE DATA SET : 9.3400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.44 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.36 REMARK 200 R MERGE FOR SHELL (I) : 0.84700 REMARK 200 R SYM FOR SHELL (I) : 0.84700 REMARK 200 FOR SHELL : 0.650 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INHOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11.5 MG/ML PROTEIN IN 20MM HEPES/NAOH REMARK 280 PH7.5, 5MM DTT, 5% GLYCEROL, 0.1M NACL MIXED 3:1 IN 600 NL WITH REMARK 280 0.1M CA ACETATE, 12% PEG 8K, 0.1M NA CACODYLATE PH5.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.02550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 593 REMARK 465 GLY A 594 REMARK 465 ALA A 595 REMARK 465 VAL A 596 REMARK 465 GLY A 597 REMARK 465 ASP A 598 REMARK 465 GLY A 599 REMARK 465 PRO A 600 REMARK 465 PRO A 601 REMARK 465 ARG A 602 REMARK 465 LEU A 638 REMARK 465 ASP A 639 REMARK 465 PHE A 640 REMARK 465 PRO A 641 REMARK 465 LEU A 642 REMARK 465 ASN A 643 REMARK 465 GLU A 730 REMARK 465 GLY A 731 REMARK 465 ALA A 732 REMARK 465 PRO A 733 REMARK 465 GLY A 734 REMARK 465 ASP A 735 REMARK 465 THR A 912 REMARK 465 VAL A 913 REMARK 465 HIS A 914 REMARK 465 HIS A 915 REMARK 465 HIS A 916 REMARK 465 HIS A 917 REMARK 465 HIS A 918 REMARK 465 HIS A 919 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1143 O HOH A 1247 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 636 93.61 -58.81 REMARK 500 ARG A 765 -15.20 82.89 REMARK 500 ASP A 766 45.24 -145.22 REMARK 500 ALA A 783 -164.13 -123.11 REMARK 500 ASP A 784 87.13 -159.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1359 DISTANCE = 6.12 ANGSTROMS REMARK 525 HOH A1360 DISTANCE = 6.41 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue D6W A 1001 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FER RELATED DB: PDB DBREF 6FEW A 593 913 UNP Q08345 DDR1_HUMAN 574 894 SEQADV 6FEW A UNP Q08345 GLY 711 DELETION SEQADV 6FEW A UNP Q08345 GLN 712 DELETION SEQADV 6FEW A UNP Q08345 ALA 713 DELETION SEQADV 6FEW A UNP Q08345 ALA 714 DELETION SEQADV 6FEW A UNP Q08345 GLN 715 DELETION SEQADV 6FEW A UNP Q08345 GLY 716 DELETION SEQADV 6FEW HIS A 914 UNP Q08345 EXPRESSION TAG SEQADV 6FEW HIS A 915 UNP Q08345 EXPRESSION TAG SEQADV 6FEW HIS A 916 UNP Q08345 EXPRESSION TAG SEQADV 6FEW HIS A 917 UNP Q08345 EXPRESSION TAG SEQADV 6FEW HIS A 918 UNP Q08345 EXPRESSION TAG SEQADV 6FEW HIS A 919 UNP Q08345 EXPRESSION TAG SEQRES 1 A 321 PRO GLY ALA VAL GLY ASP GLY PRO PRO ARG VAL ASP PHE SEQRES 2 A 321 PRO ARG SER ARG LEU ARG PHE LYS GLU LYS LEU GLY GLU SEQRES 3 A 321 GLY GLN PHE GLY GLU VAL HIS LEU CYS GLU VAL ASP SER SEQRES 4 A 321 PRO GLN ASP LEU VAL SER LEU ASP PHE PRO LEU ASN VAL SEQRES 5 A 321 ARG LYS GLY HIS PRO LEU LEU VAL ALA VAL LYS ILE LEU SEQRES 6 A 321 ARG PRO ASP ALA THR LYS ASN ALA ARG ASN ASP PHE LEU SEQRES 7 A 321 LYS GLU VAL LYS ILE MET SER ARG LEU LYS ASP PRO ASN SEQRES 8 A 321 ILE ILE ARG LEU LEU GLY VAL CYS VAL GLN ASP ASP PRO SEQRES 9 A 321 LEU CYS MET ILE THR ASP TYR MET GLU ASN GLY ASP LEU SEQRES 10 A 321 ASN GLN PHE LEU SER ALA HIS GLN LEU GLU ASP LYS ALA SEQRES 11 A 321 ALA GLU GLY ALA PRO GLY ASP PRO THR ILE SER TYR PRO SEQRES 12 A 321 MET LEU LEU HIS VAL ALA ALA GLN ILE ALA SER GLY MET SEQRES 13 A 321 ARG TYR LEU ALA THR LEU ASN PHE VAL HIS ARG ASP LEU SEQRES 14 A 321 ALA THR ARG ASN CYS LEU VAL GLY GLU ASN PHE THR ILE SEQRES 15 A 321 LYS ILE ALA ASP PHE GLY MET SER ARG ASN LEU TYR ALA SEQRES 16 A 321 GLY ASP TYR TYR ARG VAL GLN GLY ARG ALA VAL LEU PRO SEQRES 17 A 321 ILE ARG TRP MET ALA TRP GLU CYS ILE LEU MET GLY LYS SEQRES 18 A 321 PHE THR THR ALA SER ASP VAL TRP ALA PHE GLY VAL THR SEQRES 19 A 321 LEU TRP GLU VAL LEU MET LEU CYS ARG ALA GLN PRO PHE SEQRES 20 A 321 GLY GLN LEU THR ASP GLU GLN VAL ILE GLU ASN ALA GLY SEQRES 21 A 321 GLU PHE PHE ARG ASP GLN GLY ARG GLN VAL TYR LEU SER SEQRES 22 A 321 ARG PRO PRO ALA CYS PRO GLN GLY LEU TYR GLU LEU MET SEQRES 23 A 321 LEU ARG CYS TRP SER ARG GLU SER GLU GLN ARG PRO PRO SEQRES 24 A 321 PHE SER GLN LEU HIS ARG PHE LEU ALA GLU ASP ALA LEU SEQRES 25 A 321 ASN THR VAL HIS HIS HIS HIS HIS HIS HET D6W A1001 33 HETNAM D6W 2-[8-(2~{H}-INDAZOL-5-YLCARBONYL)-4-OXIDANYLIDENE-1- HETNAM 2 D6W PHENYL-1,3,8-TRIAZASPIRO[4.5]DECAN-3-YL]-~{N}-METHYL- HETNAM 3 D6W ETHANAMIDE FORMUL 2 D6W C24 H26 N6 O3 FORMUL 3 HOH *260(H2 O) HELIX 1 AA1 PRO A 606 SER A 608 5 3 HELIX 2 AA2 SER A 631 LEU A 635 5 5 HELIX 3 AA3 THR A 662 LEU A 679 1 18 HELIX 4 AA4 ASP A 708 ALA A 715 1 8 HELIX 5 AA5 SER A 739 LEU A 760 1 22 HELIX 6 AA6 ALA A 768 ARG A 770 5 3 HELIX 7 AA7 GLU A 776 PHE A 778 5 3 HELIX 8 AA8 ARG A 789 TYR A 796 5 8 HELIX 9 AA9 PRO A 806 MET A 810 5 5 HELIX 10 AB1 ALA A 811 GLY A 818 1 8 HELIX 11 AB2 THR A 821 MET A 838 1 18 HELIX 12 AB3 THR A 849 ASP A 863 1 15 HELIX 13 AB4 PRO A 877 TRP A 888 1 12 HELIX 14 AB5 GLU A 891 ARG A 895 5 5 HELIX 15 AB6 PRO A 897 ASN A 911 1 15 SHEET 1 AA1 5 LEU A 610 GLU A 618 0 SHEET 2 AA1 5 GLY A 622 VAL A 629 -1 O LEU A 626 N GLU A 614 SHEET 3 AA1 5 LEU A 651 LEU A 657 -1 O ILE A 656 N GLU A 623 SHEET 4 AA1 5 CYS A 698 ASP A 702 -1 O THR A 701 N ALA A 653 SHEET 5 AA1 5 GLY A 689 CYS A 691 -1 N CYS A 691 O CYS A 698 SHEET 1 AA2 2 GLN A 717 LEU A 718 0 SHEET 2 AA2 2 THR A 737 ILE A 738 1 O ILE A 738 N GLN A 717 SHEET 1 AA3 2 CYS A 772 VAL A 774 0 SHEET 2 AA3 2 ILE A 780 ILE A 782 -1 O LYS A 781 N LEU A 773 CISPEP 1 ASP A 695 PRO A 696 0 -3.06 SITE 1 AC1 15 VAL A 624 ALA A 653 LYS A 655 GLU A 672 SITE 2 AC1 15 MET A 676 ILE A 685 MET A 699 THR A 701 SITE 3 AC1 15 TYR A 703 MET A 704 LEU A 773 ALA A 783 SITE 4 AC1 15 ASP A 784 PHE A 785 HOH A1187 CRYST1 40.580 62.051 63.419 90.00 106.58 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024643 0.000000 0.007338 0.00000 SCALE2 0.000000 0.016116 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016452 0.00000